Table 1. Sex- and age-specific prevalence of hyperuricemia in study population.
Hyperuricemia | ||||||||||||
Male(n=2766) | Female(n=1606) | Total (n=4372) | ||||||||||
Screened | Cases | Prevalence | p-value for | Screened | Cases | Prevalence | p-value for | Screened | Cases | Prevalence | p-value for | |
No | No | (%) | χ2-test | No | No | (%) | χ2-test | No | No | (%) | χ2-test | |
for trend | for trend | for trend | ||||||||||
65-74 | 1537 | 430 | 28.0% | 0,015 | 903 | 250 | 27.7% | 0,008 | 2440 | 680 | 27.9% | <0.0001 |
75-84 | 1033 | 343 | 33.2% | 575 | 193 | 33.6% | 1608 | 536 | 33.3% | |||
≥85 | 196 | 63 | 32.1% | 128 | 49 | 38.3% | 324 | 112 | 34.6% | |||
Total | 2766 | 836 | 30.2% | 1606 | 492 | 30.6% | 4372 | 1328 | 30.4% |